Adrenomedullin administered peripherally in the rabbit (at doses of 1.25, 2
.5 and 5 mu g/kg) caused a dose-dependent conjunctival hyperemia accompanie
d by an increase of inflammatory cell number and prostaglandin E-2 concentr
ation in the aqueous humor, and of uveal vascular response and myeloperoxid
ase activity. The inflammatory effect of the peptide, injected at the dose
of 5 mu g/kg, was abolished by pretreatment with the inhibitor of nitric ox
ide synthase, N-G-nitro-L-arginine methylester (50 mg/kg, i.v.). Moreover,
the i.v. pretreatment with the calcitonin gene-related peptide 8-37 fragmen
t (calcitonin gene-related peptide, CGRP-(8-37), 2.5 mu g/kg), receptor ant
agonist of CGRP, did not inhibit the conjunctival hyperemia. In contrast, t
he i.v. pretreatment with the adrenomedullin receptor antagonist, adrenomed
uilin-(22-52) fragment (2.5 mu g/kg), abolished adrenomedullin-induced ocul
ar inflammation. These results suggest that adrenomedullin causes conjuncti
val hyperemia, and this effect involves the nitric oxide system acting thro
ugh specific adrenomedullin receptors. (C) 2000 Elsevier Science B.V. All r
ights reserved.